A Phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis

Journal of Infectious Diseases

Volumn 201, Issue 11, 2010, Pages 1729-1735

  Hook III, Edward W ^a   Behets, Frieda ^b   Van Damme, Kathleen ^c   Ravelomanana, Noro ^c   Leone, Peter ^b   Sena, Arlene C ^b   Martin, David ^d   Langley, Carol ^e   McNeil, Linda ^f   Wolff, Mark ^g  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e INDIANA UNIVERSITY   (United States)

^f FAMILY HEALTH INTERNATIONAL   (United States)

^g EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN;

AGEUSIA; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SINGLE DRUG DOSE; SKIN TOXICITY; SYPHILIS;

EID: 77951892761     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652239     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2006. Atlanta, Georgia: US Department of Health and Human Services, 2007.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. Current United Stated guidelines for treatment of STDs including syphilis. MMWR 2006; 55:22-35.
3. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270: 2456-2463. (Pubitemid 23342295)
4. Hook EW III, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29:486-490. (Pubitemid 34851786)
5. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236-1244. (Pubitemid 41345945)
6. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997;46:1-56.
7. Larsen SA, Pope V, Johnson RE, Kennedy EJ. A manual of tests for syphilis. 9th ed. Washington DC: American Public Health Association, 1998:3-6.
8. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997;337:307-314.
9. Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 2000; 44:806-807.
10. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351:154-158.
11. Holmes KK. Azithromycin versus penicillin G benzathine for early syphilis. N Engl J Med 2005;353:1291-1293. (Pubitemid 41345954)
12. Martin IE, Gu W, Yang Y, Tsang RS. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin Infect Dis 2009;49:515-521.
13. Van Damme K, Behets F, Vavelomanana N, et al. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis 2009; 36(12):775-776.